Cervical cancer screening

Edward E. Partridge, Nadeem Abu-Rustum, Susan Campos, Patrick J. Fahey, Benjamin E. Greer, Subodh M Lele, Richard W. Lieberman, Gary H. Lipscomb, Mark Morgan, Maria Enriqueta R Nava, R. Kevin Reynolds, Diljeet K. Singh, Karen Smith-McCune, Nelson Teng, Cornelia Liu Trimble, Fidel Valea, Sharon Wilczynski

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.

Original languageEnglish (US)
Pages (from-to)58-82
Number of pages25
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume6
Issue number1
StatePublished - Jan 1 2008

Fingerprint

Colposcopy
Early Detection of Cancer
Uterine Cervical Neoplasms
Cell Biology
DNA
Women's Health
Practice Guidelines
Viruses
Carcinoma
Biopsy
Pregnancy

Keywords

  • Biopsy
  • Cancer screening
  • Cervical cancer
  • Cold-knife conization
  • Colposcopy
  • Human papillomavirus testing
  • Intraepithelial neoplasia
  • Liquid-based cytology
  • Loop electrosurgical excision procedure
  • NCCN clinical practice guidelines
  • Pap test
  • Papanicolaou test

ASJC Scopus subject areas

  • Oncology

Cite this

Partridge, E. E., Abu-Rustum, N., Campos, S., Fahey, P. J., Greer, B. E., Lele, S. M., ... Wilczynski, S. (2008). Cervical cancer screening. JNCCN Journal of the National Comprehensive Cancer Network, 6(1), 58-82.

Cervical cancer screening. / Partridge, Edward E.; Abu-Rustum, Nadeem; Campos, Susan; Fahey, Patrick J.; Greer, Benjamin E.; Lele, Subodh M; Lieberman, Richard W.; Lipscomb, Gary H.; Morgan, Mark; Nava, Maria Enriqueta R; Reynolds, R. Kevin; Singh, Diljeet K.; Smith-McCune, Karen; Teng, Nelson; Trimble, Cornelia Liu; Valea, Fidel; Wilczynski, Sharon.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 6, No. 1, 01.01.2008, p. 58-82.

Research output: Contribution to journalReview article

Partridge, EE, Abu-Rustum, N, Campos, S, Fahey, PJ, Greer, BE, Lele, SM, Lieberman, RW, Lipscomb, GH, Morgan, M, Nava, MER, Reynolds, RK, Singh, DK, Smith-McCune, K, Teng, N, Trimble, CL, Valea, F & Wilczynski, S 2008, 'Cervical cancer screening', JNCCN Journal of the National Comprehensive Cancer Network, vol. 6, no. 1, pp. 58-82.
Partridge EE, Abu-Rustum N, Campos S, Fahey PJ, Greer BE, Lele SM et al. Cervical cancer screening. JNCCN Journal of the National Comprehensive Cancer Network. 2008 Jan 1;6(1):58-82.
Partridge, Edward E. ; Abu-Rustum, Nadeem ; Campos, Susan ; Fahey, Patrick J. ; Greer, Benjamin E. ; Lele, Subodh M ; Lieberman, Richard W. ; Lipscomb, Gary H. ; Morgan, Mark ; Nava, Maria Enriqueta R ; Reynolds, R. Kevin ; Singh, Diljeet K. ; Smith-McCune, Karen ; Teng, Nelson ; Trimble, Cornelia Liu ; Valea, Fidel ; Wilczynski, Sharon. / Cervical cancer screening. In: JNCCN Journal of the National Comprehensive Cancer Network. 2008 ; Vol. 6, No. 1. pp. 58-82.
@article{f7e6ccee40f24ea482780769151a77c5,
title = "Cervical cancer screening",
abstract = "Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.",
keywords = "Biopsy, Cancer screening, Cervical cancer, Cold-knife conization, Colposcopy, Human papillomavirus testing, Intraepithelial neoplasia, Liquid-based cytology, Loop electrosurgical excision procedure, NCCN clinical practice guidelines, Pap test, Papanicolaou test",
author = "Partridge, {Edward E.} and Nadeem Abu-Rustum and Susan Campos and Fahey, {Patrick J.} and Greer, {Benjamin E.} and Lele, {Subodh M} and Lieberman, {Richard W.} and Lipscomb, {Gary H.} and Mark Morgan and Nava, {Maria Enriqueta R} and Reynolds, {R. Kevin} and Singh, {Diljeet K.} and Karen Smith-McCune and Nelson Teng and Trimble, {Cornelia Liu} and Fidel Valea and Sharon Wilczynski",
year = "2008",
month = "1",
day = "1",
language = "English (US)",
volume = "6",
pages = "58--82",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Cervical cancer screening

AU - Partridge, Edward E.

AU - Abu-Rustum, Nadeem

AU - Campos, Susan

AU - Fahey, Patrick J.

AU - Greer, Benjamin E.

AU - Lele, Subodh M

AU - Lieberman, Richard W.

AU - Lipscomb, Gary H.

AU - Morgan, Mark

AU - Nava, Maria Enriqueta R

AU - Reynolds, R. Kevin

AU - Singh, Diljeet K.

AU - Smith-McCune, Karen

AU - Teng, Nelson

AU - Trimble, Cornelia Liu

AU - Valea, Fidel

AU - Wilczynski, Sharon

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.

AB - Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.

KW - Biopsy

KW - Cancer screening

KW - Cervical cancer

KW - Cold-knife conization

KW - Colposcopy

KW - Human papillomavirus testing

KW - Intraepithelial neoplasia

KW - Liquid-based cytology

KW - Loop electrosurgical excision procedure

KW - NCCN clinical practice guidelines

KW - Pap test

KW - Papanicolaou test

UR - http://www.scopus.com/inward/record.url?scp=38949103654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949103654&partnerID=8YFLogxK

M3 - Review article

VL - 6

SP - 58

EP - 82

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -